|
AMN1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.82979999619715E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.92670365509684E-11 |
| Normal-vs-Stage2 |
9.02710000083573E-08 |
| Normal-vs-Stage3 |
2.99560000027732E-07 |
| Normal-vs-Stage4 |
3.846600E-04 |
| Stage1-vs-Stage2 |
4.618800E-01 |
| Stage1-vs-Stage3 |
6.636800E-01 |
| Stage1-vs-Stage4 |
8.346800E-01 |
| Stage2-vs-Stage3 |
8.998200E-01 |
| Stage2-vs-Stage4 |
8.336800E-01 |
| Stage3-vs-Stage4 |
9.379400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.45150000089245E-08 |
| Normal-vs-AfricanAmerican |
4.37779999995502E-06 |
| Normal-vs-Asian |
6.676100E-03 |
| Caucasian-vs-AfricanAmerican |
2.700600E-01 |
| Caucasian-vs-Asian |
9.885800E-01 |
| AfricanAmerican-vs-Asian |
7.257200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.17089999707565E-08 |
| Normal-vs-Female |
2.62589999744378E-08 |
| Male-vs-Female |
1.220990E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.15760000030107E-07 |
| Normal-vs-Extreme_Weight |
2.90010000458807E-08 |
| Normal-vs-Obese |
7.96249999268639E-09 |
| Normal-vs-Extreme_Obese |
9.621600E-02 |
| Normal_Weight-vs-Extreme_Weight |
4.040200E-01 |
| Normal_Weight-vs-Obese |
7.997800E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.807200E-01 |
| Extreme_Weight-vs-Obese |
1.732380E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.269200E-01 |
| Obese-vs-Extreme_Obese |
8.313800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.249500E-04 |
| Normal-vs-Age(41-60Yrs) |
3.33829999976665E-07 |
| Normal-vs-Age(61-80Yrs) |
6.60793642026647E-12 |
| Normal-vs-Age(81-100Yrs) |
1.12870000013032E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.300400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.868500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.782600E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.135800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.174400E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.855500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.9859000000011E-07 |
| Normal-VS-Type2 PRCC |
9.77351533038018E-12 |
| Normal-VS-KIRP CIMP |
4.439800E-03 |
| Normal-VS-Unclassified PRCC |
6.79889999855021E-08 |
| Type1 PRCC-VS-Type2 PRCC |
1.742420E-02 |
| Type1 PRCC-VS-KIRP CIMP |
4.577800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.272000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.261850E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.428200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.326600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.34080000435688E-08 |
| Normal-vs-N1 |
3.84340000000316E-05 |
| Normal-vs-N2 |
7.614100E-02 |
| N0-vs-N1 |
3.253200E-01 |
| N0-vs-N2 |
1.996790E-01 |
| N1-vs-N2 |
6.927200E-01 |
|
|
